Pharmacokinetics of metoclopramide after single oral dose administration in cirrhosis

M. Bernardi, M. R. Tame, F. Albani, R. De Palma, P. Scrivano, F. Trevisani, G. Gasbarrini

Research output: Contribution to journalArticlepeer-review


The pharmacokinetics of metoclopramide were studied after a single oral dose in 16 cirrhotic patients, eight without, and eight with ascites. Elimination half-life ranged from 5.6 to 14.2 h (mean: 9.46 ± 0.69 h) and total plasma clearance from 0.09 to 0.56 l/h per kg (0.3 ± 0.03). In comparison with data in healthy volunteers, elimination of metoclopramide in cirrhosis was greatly delayed. Despite the fact that in cirrhotics with ascites hepatic function was worse than in those without, no statistically significant differences were found in the pharmacokinetic data. Moreover, no statistically significant relationships were found between pharmacokinetic data and liver function tests. An adjustment of the dosage of metoclopramide can thus be recommended in patients with cirrhosis and portal hypertension, irrespective of their liver function.

Original languageEnglish
Pages (from-to)519-522
Number of pages4
JournalEuropean Journal of Gastroenterology and Hepatology
Issue number7
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Pharmacokinetics of metoclopramide after single oral dose administration in cirrhosis'. Together they form a unique fingerprint.

Cite this